Quick Takeaways
- HIGHBRIDGE CAPITAL MANAGEMENT LLC reported 13f holdings report, stock holdings for Q2 2017.
- Reported holdings value: $4,644,528,000.
- 797 holdings are listed in this filing snapshot.
HIGHBRIDGE CAPITAL MANAGEMENT LLC
Q2 2017 13F Holdings Report, Stock Holdings
- Signature - Title
- John Oliva - Chief Compliance Officer
- Location
- New York, NY
- Holdings as of
- 30 Jun 2017
- Value $
- $4,644,528,000
- Num holdings
- 797
- Filing time
- 14 Aug 2017, 16:06:53 UTC
- Form type
- 13F-HR
- Description
- All US holdings of this investor are reported in this report. Top holdings included BABA, MICROCHIP TECHNOLOGY INC, LAM RESEARCH CORP, INTEL CORP, and AIGWS. Confidential Treatment Requested (one or more holding(s) omitted).
- Previous filing
- Q1 2017 - 15 May 2017
- Next filing
- Q3 2017 - 14 Nov 2017
- SEC
- View on sec.gov
- Options Holdings
- Showing stock holdings, see here for options holdings
HIGHBRIDGE CAPITAL MANAGEMENT LLC Q2 2017 Portfolio
Quoteable Key Fact
"HIGHBRIDGE CAPITAL MANAGEMENT LLC reported $4,644,528,000 across 797 holdings in Q2 2017."
What Changed
- Previous comparable filing: Q1 2017.
- Value moved from $4,982,551,000 to $4,644,528,000.
Why This Matters
- This filing-level page explains what the portfolio report tells you before the holdings table.
- You can cite quarter, value, and filing timestamp directly from SEC-linked data.
Official SEC Source
Backed by Form 13F
Portfolio-level numbers on this page come from the original SEC Form 13F filing.
See Original Filing| Sym | Weight | Trade Impact | Company | Class | Share Change | Activity | Value Change $ | Value $ | * Price $ | Shares | Principal |
|---|
Filing 2017 Q2 compared to 2017 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)
Person Signing this Report on Behalf of Reporting Manager:
| Name | Title | City, State | Date |
|---|---|---|---|
| John Oliva | Chief Compliance Officer | New York, New York | 14 Aug 2017 |